France: Affluent launches capital increase exercise with subscription offer

Affluent Medical, a developer of minimally invasive medical devices for the treatment of heart and vascular diseases, has launched a €13m (US$14m) increase with preferential subscription rights. The subscription period runs until February 27, 2023. Proceeds are intended to provide the company with part of the means necessary to continue financing its needs over the…